Sign in

CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Anebulo Pharmaceuticals, Inc.

Sign in to watch
Ticker
ANEB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
851170950
Phone
737 203 5270
Business address
C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. 8-A12B Other Registration of Securities
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1/A Offering Registration Statement
  11. UPLOAD Other SEC-generated Letter
  12. FWP Offering Free Writing Prospectus
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-1 Offering Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. DRS/A Other Draft Registration Statement
  20. DRSLTR Other Correspondence Related to Draft Registration Statement

Page 10 of 11 · 204 filings